Feb 16 2012
The American College of Allergy, Asthma and Immunology (ACAAI) recognizes Teva Respiratory for its continued leadership and support of important educational issues related to respiratory health, particularly under diagnosed and poorly managed asthma and exercise-induced bronchoconstriction. ACAAI announced today that they will partner again this year with Teva Respiratory to bring free asthma screenings to communities nationwide.
Almost 130,000 people have been screened since the start of the Nationwide Asthma Screening Program, with half of those screened referred for a diagnosis. Continued financial support by Teva Respiratory provides the funding for the public education materials, publicity and resources needed to conduct screenings. On a local level, Teva representatives help at three out of every four screenings.
"We are thrilled to once again partner with Teva," said allergist John Winder, M.D. chair of the ACAAI Nationwide Asthma Screening Program. "This program would not be possible without their continued support."
Study: Inhalers for asthma and COPD come with a steep environmental cost